Pulmonary Fibrosis and PDE4B – Video
Pulmonary Fibrosis and PDE4B – Video
Discover the pathophysiology of pulmonary fibrosis.
What you'll learn:
- Which patients may develop pulmonary fibrosis.
- The inflammatory and fibrotic mechanisms that contribute to the pathogenesis and progression of pulmonary fibrosis, including:
- how an initial injury to the epithelium can trigger an abnormal healing response
- how recurring injury results in a proinflammatory and profibrotic milieu and develops into a self-sustaining process of inflammation and fibrosis.
- Current therapeutic targets for pulmonary fibrosis, including phosphodiesterase 4 (PDE4).
- The effects of PDE4 inhibition on epithelial cells, microphages, and fibroblasts.
- Potential side effects of PDE4 inhibition and their impact on the efficacy of potential therapeutic treatments.
Related Resources
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Diagnosis of HP in Adults - Clinical Practice Guideline
Guidelines from the American Thoracic Society offering a systematic approach to diagnosing hypersensitivity pneumonitis (HP).
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Autoimmune Disease-Associated Interstitial Lung Disease - Slide Deck
Review autoimmune connective tissue disorders (CTDs) associated with ILD.
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Hypersensitivity Pneumonitis - Slide Deck
Discover the characteristics, epidemiology, and pathogenesis of HP.
View Resource
